Monique C.A. Duyndam

1.1k citations

18 papers · 931 indexed · h-index 13

Co-authors: Epie Boven Herbert M. Pinedo A. Zantema Hans van Dam A.J. van der Eb Peter Angel Antonio Llombart Bosch Peter Herrlich
Topics: Cancer, Hypoxia, and Metabolism (6 papers)Angiogenesis and VEGF in Cancer (6 papers)Virus-based gene therapy research (4 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: Nucleic Acids Research Journal of Biological ChemistrySHILAP Revista de lepidopterología
Partner nations: Netherlands United States Germany

In The Last Decade

Monique C.A. Duyndam

18 papers receiving 916 citations

Peers

Countries citing papers authored by Monique C.A. Duyndam

Since Specialization

Citations

This map shows the geographic impact of Monique C.A. Duyndam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monique C.A. Duyndam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monique C.A. Duyndam more than expected).

Fields of papers citing papers by Monique C.A. Duyndam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monique C.A. Duyndam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monique C.A. Duyndam. The network helps show where Monique C.A. Duyndam may publish in the future.

Co-authorship network of co-authors of Monique C.A. Duyndam

This figure shows the co-authorship network connecting the top 25 collaborators of Monique C.A. Duyndam. A scholar is included among the top collaborators of Monique C.A. Duyndam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monique C.A. Duyndam. Monique C.A. Duyndam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells 2016 ·PLoS ONE ·(unknown),Monique C.A. Duyndam,Ester M. Weijers,(unknown),Pieter Koolwijk	13
2	Basic fibroblast growth factor-mediated overexpression of vascular endothelial growth factor in 1F6 human melanoma cells is regulated by activation of PI-3K and p38 MAPK. 2009 ·SHILAP Revista de lepidopterología ·(unknown),Linda J.W. Bosch,Monique C.A. Duyndam,(unknown),Maarten L. Janmaat,Epie Boven	4
3	Basic Fibroblast Growth Factor-Mediated Overexpression of Vascular Endothelial Growth Factor in 1F6 Human Melanoma Cells is Regulated by Activation of PI-3K and p38 MAPK 2009 ·Analytical Cellular Pathology ·(unknown),Linda J.W. Bosch,Monique C.A. Duyndam,(unknown),Maarten L. Janmaat,Epie Boven	5
4	The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis 2007 ·Melanoma Research ·(unknown),Monique C.A. Duyndam,Jeroen A.M. Beliën,(unknown),Herbert M. Pinedo,Epie Boven	6
5	Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells 2007 ·Biochemical Pharmacology ·Monique C.A. Duyndam,(unknown),Josephine C. Dorsman,Davy Rockx,Herbert M. Pinedo,Epie Boven	63
6	CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells 2006 ·British Journal of Cancer ·(unknown),Monique C.A. Duyndam,(unknown),(unknown),Linda H. Shapiro,Herbert M. Pinedo,H J Broxterman,Epie Boven	37
7	Basic fibroblast growth factor (bFGF) in melanoma cells can upregulate vascular endothelial growth factor (VEGF) and CD13/aminopeptidase N, which is associated with accelerated growth, invasion and vascularization 2006 ·Melanoma Research ·(unknown),Monique C.A. Duyndam,Linda J.W. Bosch,Maribelis Ruiz,Maaike van Berkel,(unknown),H J Broxterman,Linda H. Shapiro,Herbert M. Pinedo,Epie Boven	2
8	Reduced Growth, Increased Vascular Area, and Reduced Response to Cisplatin in CD13-Overexpressing Human Ovarian Cancer Xenografts 2004 ·Clinical Cancer Research ·Yvette van Hensbergen,Henk J. Broxterman,Sareena Rana,P. J. van Diest,Monique C.A. Duyndam,Klaas Hoekman,Herbert M. Pinedo,Epie Boven	44
9	Evidence for a Role of p38 Kinase in Hypoxia-inducible Factor 1-independent Induction of Vascular Endothelial Growth Factor Expression by Sodium Arsenite 2003 ·Journal of Biological Chemistry ·Monique C.A. Duyndam,Saskia Hulscher,Elsken van der Wall,Herbert M. Pinedo,Epie Boven	69
10	Vascular Endothelial Growth Factor-165 Overexpression Stimulates Angiogenesis and Induces Cyst Formation and Macrophage Infiltration in Human Ovarian Cancer Xenografts 2002 ·American Journal Of Pathology ·Monique C.A. Duyndam,(unknown),Hennie M.M. Schlüper,Henk M.W. Verheul,P. J. van Diest,Georg Kraal,Herbert M. Pinedo,Epie Boven	68
11	Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel 2002 ·Biochemical Pharmacology ·(unknown),(unknown),Monique C.A. Duyndam,Herbert M. Pinedo,Epie Boven	51
12	Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor Arsenite 2001 ·Journal of Biological Chemistry ·Monique C.A. Duyndam,(unknown),(unknown),Herbert M. Pinedo,Epie Boven	104
13	The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A 1999 ·Oncogene ·Monique C.A. Duyndam,Hans van Dam,Paul H.M. Smits,(unknown),Alex J. van der Eb,A. Zantema	27
14	Angiogenesis and ovarian cancer 1998 ·Monique C.A. Duyndam,(unknown),Epie Boven	2
15	Altered AP-1/ATF complexes in adenovirus-E1-transformed cells due to EIA-dependent induction of ATF3. 1996 ·PubMed ·(unknown),Monique C.A. Duyndam,Peter Angel,Rolf P. de Groot,(unknown),Peter Elfferich,A.J. van der Eb,A. Zantema	18
16	The CR1 and CR3 domains of the adenovirus type 5 E1A proteins can independently mediate activation of ATF-2 1996 ·Journal of Virology ·Monique C.A. Duyndam,Hans van Dam,A.J. van der Eb,A. Zantema	15
17	Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. 1993 ·The EMBO Journal ·Hans van Dam,Monique C.A. Duyndam,Robbert J. Rottier,Antonio Llombart Bosch,(unknown),Peter Herrlich,A. Zantema,Peter Angel,A.J. van der Eb	351
18	Antigenic variation inTrypanosoma brucei: a telomeric expression site for variant-specific surface glycoprotein genes with novel features 1991 ·Nucleic Acids Research ·Joost C.B.M. Zomerdijk,Rudo Kieft,Monique C.A. Duyndam,Paul G. Shiels,Piet Borst	52

About Monique C.A. Duyndam

Monique C.A. Duyndam is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 18 papers that have together received 931 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Cancer Research (249 citations), Molecular Biology (623 citations) and Oncology (233 citations). Monique C.A. Duyndam has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Epie Boven, Herbert M. Pinedo, A. Zantema, Hans van Dam, A.J. van der Eb, Peter Angel, Antonio Llombart Bosch, Peter Herrlich, Robbert J. Rottier and Elsken van der Wall. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact